End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.19 CNY | -0.96% | +2.57% | -10.12% |
08:59am | RAAS Blood Products' 2023 Profit Falls 5% Despite 21% Revenue Growth | MT |
04-15 | Grifols Plans to Appoint Independent Directors Only to Audit, Compensation Committees | MT |
Chart calendar Shanghai RAAS Blood Products Co., Ltd.
Upcoming events on Shanghai RAAS Blood Products Co., Ltd.
Past events on Shanghai RAAS Blood Products Co., Ltd.
11/04/2024 | Q4 2023 Earnings Release |
07/02/2024 06:00 | Extraordinary Shareholders Meeting |
11/12/2023 06:00 | Extraordinary Shareholders Meeting |
24/10/2023 | Q3 2023 Earnings Release |
29/08/2023 | Q2 2023 Earnings Release |
16/08/2023 07:00 | Extraordinary Shareholders Meeting |
22/05/2023 06:00 | Annual General Meeting |
27/04/2023 | Q1 2023 Earnings Release |
24/04/2023 | Q4 2022 Earnings Release |
29/12/2022 05:00 | Extraordinary Shareholders Meeting |
28/10/2022 | Q3 2022 Earnings Release |
29/08/2022 | Interim 2022 Earnings Release |
14/06/2022 06:00 | Annual General Meeting |
29/04/2022 | Q1 2022 Earnings Release |
27/04/2022 | FY 2021 Earnings Release |
14/02/2022 05:00 | Extraordinary Shareholders Meeting |
27/10/2021 | Q3 2021 Earnings Release |
19/08/2021 | Interim 2021 Earnings Release |
30/07/2021 06:00 | Extraordinary Shareholders Meeting |
20/05/2021 06:00 | Annual General Meeting |
Past dividends on Shanghai RAAS Blood Products Co., Ltd.
12/06/2023 | Annual 0.03 CNY |
06/07/2022 | Annual 0.028 CNY |
01/07/2021 | Annual 0.025 CNY |
14/07/2020 | Annual 0.01 CNY |
27/06/2018 | Annual 0.017 CNY |
19/06/2017 | Annual 0.03 CNY |
26/05/2016 | Annual 0.05 CNY |
08/04/2015 | Annual 0.1 CNY |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 7 964 7 799 2.11% |
EBITDA Million CNY | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 2 395 2 572 -6.9% |
EBIT Million CNY | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 2 225 2 712 -17.94% |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 2 204 2 703 -18.45% |
Net income Million CNY | Released Forecast Spread | 1 324 | 1 295 | 1 880 | 1 779 2 173 -18.12% |
EPS CNY | Released Forecast Spread | 0,21 | 0,19 | 0,28 | 0,27 0,33 -16.92% |
Announcement Date | 22/04/21 | 27/04/22 | 24/04/23 | 28/04/24 |
Quarterly results
Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 2 029 1 814 11.83% | 2 322 | 2 215 | 2 284 | 2 226 | |
Net income Million CNY | Released Forecast Spread | 549 | |||||
EPS CNY | Released Forecast Spread | 0,08 | 0,05 | 0,12 | 0,09 | 0,11 | 0,06 |
Announcement Date | 24/10/23 | 28/04/24 | - | - | - | - |
Past sector events for Shanghai RAAS Blood Products Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002252 Stock
- Calendar Shanghai RAAS Blood Products Co., Ltd.